ADVFN - ニュース

S&P 500

5,431.60

-0.04%

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/17	13 : 30	PR Newswire (US)	Hotchkiss Insurance Expands Partnership with Chris Bailey, Chase Fondren, and Dustin Rivera
2024/06/17	13 : 26	GlobeNewswire Inc.	OKX Announces Partnership with CertiK for Fast Pass Program
2024/06/17	13 : 22	PR Newswire (US)	New Book Helps Readers Change their Mindset to Align with their Authentic Self
2024/06/17	13 : 04	Alliance News	UK house prices flat on-month in June after spiking to record in May
2024/06/17	13 : 01	Business Wire	Cal Poly Releases First “Imagineering” Report to Anticipate Novel Scenarios for Outer Space Cyberattacks
2024/06/17	13 : 01	PR Newswire (US)	American Power Systems unveils Toyota Land Cruiser 300 dual alternator bracket kit at Eurosatory 2024
2024/06/17	13 : 01	PR Newswire (US)	IAS EXPANDS BRAND SAFETY AND SUITABILITY MEASUREMENT FOR YOUTUBE TO INCLUDE PERFORMANCE MAX AND DEMAND GEN CAMPAIGNS	NASDAQ:IAS	Intergral Ad Science Holding Corporation
2024/06/17	13 : 01	PR Newswire (US)	American Power Systems unveils Toyota Land Cruiser 300 dual alternator bracket kit at Eurosatory 2024
2024/06/17	13 : 00	PR Newswire (US)	Christian Media LLC Exposes Methods Utilized by Occult Religions to Recruit and Control Members
2024/06/17	13 : 00	PR Newswire (US)	BSI Celebrates 45 Years of Innovating Payroll Tax Solutions
2024/06/17	13 : 00	PR Newswire (US)	Retired Lieutenant Commander for the Royal Australian Navy Shares His Part in Military History
2024/06/17	13 : 00	PR Newswire (US)	IBM and The All England Lawn Tennis Club Launch New Generative AI Feature for Personalised Player Stories at Wimbledon	NYSE:IBM	International Business Machines Corp
2024/06/17	12 : 56	Crypto Briefing	Financial advisors still figuring out Bitcoin spot ETFs, says BlackRock CIO	COIN:BTCUSD	Bitcoin
2024/06/17	11 : 00	PR Newswire (US)	TECNO Launches SPARK 20 Pro 5G - the SPARK 20 Series' First 5G Smartphone with Powerful Performance and Entertainment Upgrades
2024/06/17	10 : 37	Cointelegraph	SEC shoots down Ripple’s argument for a lower penalty	COIN:XRPUSD	Ripple
2024/06/17	10 : 32	PR Newswire (US)	Metz, in Partnership with AI TECH, Introduces Advanced Interactive Flat Panel to Middle East Market
2024/06/17	10 : 30	Cointelegraph	Solana sandwich bot makes $30M from MEV arbitrage in 2 months	COIN:SOLUSD	Solana
2024/06/17	10 : 00	Business Wire	VCTC Kicks Off Plugfest to Advance Digital Keys by Enhancing Ultra-Wideband Technology
2024/06/17	10 : 00	PR Newswire (US)	TIER IV secures additional $54 Million in Series B funding: Deploying Level 4 autonomous driving systems across Japan
2024/06/17	10 : 00	PR Newswire (US)	Casio to Release G-SHOCK with Workout Logs and More Comfortable Fit
2024/06/17	10 : 00	PR Newswire (US)	TIER IV and Suzuki form capital and business alliance: Advancing regional mobility with autonomous driving technology
2024/06/17	09 : 38	PR Newswire (US)	Florida flair helps Prince win his first Bassmaster Elite Series trophy at Wheeler Lake
2024/06/17	09 : 30	PR Newswire (Canada)	Avis aux médias - Itinéraire du premier ministre pour le lundi 17 juin 2024
2024/06/17	09 : 27	GlobeNewswire Inc.	MULTIMEDIA UPDATE - Closing Ceremony of the 1st China (Shenyang) Comedy Film Week and the Comedy Film Festival Was Held
2024/06/17	09 : 27	GlobeNewswire Inc.	MULTIMEDIA UPDATE - Closing Ceremony of the 1st China (Shenyang) Comedy Film Week and the Comedy Film Festival Was Held
2024/06/17	09 : 27	PR Newswire (Canada)	Media Advisory - Prime Minister's itinerary for Monday, June 17, 2024
2024/06/17	09 : 14	Business Wire	Celltrion präsentiert auf dem EULAR 2024 vielversprechende Ergebnisse der Phase-III-Studie für CT-P47, einem Biosimilar-Kandidaten von RoActemra® (Tocilizumab) bei Patienten mit rheumatoider Arthritis (RA)
2024/06/17	09 : 14	Business Wire	Celltrion présente à EULAR 2024 les résultats prometteurs d’une étude de phase III sur le CT-P47, un candidat biosimilaire de RoActemra® (tocilizumab), menée sur des patients atteints de polyarthrite rhumatoïde (PR)
2024/06/17	09 : 13	Business Wire	Celltrion presenta risultati promettenti all'EULAR 2024 nello studio di fase III per CT-P47, candidato biosimilare di RoActemra® (tocilizumab) in pazienti affetti da artrite reumatoide (AR)
2024/06/17	09 : 07	PR Newswire (US)	A' Design Award & Competition Announces Call for Entries for 2025 Edition